These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 35747984)
1. Development and Validation of a Hypoxia-related Prognostic Model for Ovarian Cancer. Xie L; Pan M; Zhang Z; Jiang X; Chen Y; Liu G; Chen Y; Zeng Y; Guan J; Lu R; Zeng L Recent Pat Anticancer Drug Discov; 2022; 18(2):161-173. PubMed ID: 35747984 [TBL] [Abstract][Full Text] [Related]
2. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer. Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J Front Genet; 2022; 13():1001239. PubMed ID: 36425071 [No Abstract] [Full Text] [Related]
3. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer. Fei H; Han X; Wang Y; Li S J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138 [TBL] [Abstract][Full Text] [Related]
4. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer. Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197 [TBL] [Abstract][Full Text] [Related]
5. Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer. Zhao S; Zhang X; Gao F; Chi H; Zhang J; Xia Z; Cheng C; Liu J Front Endocrinol (Lausanne); 2023; 14():1145797. PubMed ID: 36950684 [TBL] [Abstract][Full Text] [Related]
6. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analyses of mitophagy-related genes and mitophagy-related lncRNAs for patients with ovarian cancer. Zheng J; Jiang S; Lin X; Wang H; Liu L; Cai X; Sun Y BMC Womens Health; 2024 Jan; 24(1):37. PubMed ID: 38218807 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a 9-gene signature for the prognosis of ovarian cancer by integrated bioinformatical analysis. Chen S; Yang M; Yang H; Tang Q; Gu C; Wei W Ann Transl Med; 2022 Oct; 10(19):1059. PubMed ID: 36330389 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer. Yu J; Liu TT; Liang LL; Liu J; Cai HQ; Zeng J; Wang TT; Li J; Xiu L; Li N; Wu LY Cancer Cell Int; 2021 Jul; 21(1):353. PubMed ID: 34229669 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer. Liu J; Liu Y; Yang C; Liu J; Hao J Transl Oncol; 2023 Nov; 37():101762. PubMed ID: 37619523 [TBL] [Abstract][Full Text] [Related]
11. Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database. Zhang Z; Li Q; Li A; Wang F; Li Z; Meng Y; Zhang Q Transl Androl Urol; 2021 Dec; 10(12):4353-4364. PubMed ID: 35070817 [TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of the Diagnostic Characteristic Genes of Ovarian Cancer by Bioinformatics and Machine Learning. Liu J; Liu L; Antwi PA; Luo Y; Liang F Front Genet; 2022; 13():858466. PubMed ID: 35719392 [No Abstract] [Full Text] [Related]
13. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
14. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
15. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer. Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981 [TBL] [Abstract][Full Text] [Related]
16. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
17. Development of a five-gene signature as a novel prognostic marker in ovarian cancer. Wang R; Ye XH; Zhao XL; Liu JL; Zhang CY Neoplasma; 2019 May; 66(3):343-349. PubMed ID: 30569721 [TBL] [Abstract][Full Text] [Related]
18. Establishment and Validation of a Tumor Microenvironment Prognostic Model for Predicting Bladder Cancer Survival Status Based on Integrated Bioinformatics Analyses. Chen Q; Yin G; He X; Jiang T; Zhou H; Wu Y; Li Y Evid Based Complement Alternat Med; 2022; 2022():4351005. PubMed ID: 36225190 [TBL] [Abstract][Full Text] [Related]
19. A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer. Wang L Int J Gen Med; 2021; 14():10337-10350. PubMed ID: 34992448 [TBL] [Abstract][Full Text] [Related]
20. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma. Yue C; Ma H; Zhou Y PeerJ; 2019; 7():e8128. PubMed ID: 31803536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]